XML 160 R145.htm IDEA: XBRL DOCUMENT v3.25.1
Note 20 - Condensed financial information of the parent company: Condensed Cash Flow Statement (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities      
Net (loss) income attributable to Tungray Technologies Inc $ (480,019) $ 856,536 $ 2,851,467
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities      
Increase (Decrease) in Prepaid Expense 530,103 (275,082) (221,842)
Net cash used in operating activities (811,889) 451,021 3,638,067
Cash flows from investing activities      
Net cash used in investing activities (2,784,052) (81,745) (104,120)
Cash flows from financing activities      
Proceeds from issuance of shares upon IPO 5,000,000 0 0
Proceeds from issuance of shares pursuant to exercise of over-allotment 413,940 0 0
Payments of initial public offering costs (1,418,521) (474,972) (680,125)
Net cash provided by (used in) financing activities 2,792,522 (2,805,308) (1,397,286)
Effect of exchange rate change on cash and restricted cash (526,628) 108,141 (342,913)
Cash and restricted cash - beginning of the year 10,802,405 13,130,296 11,336,548
Cash and restricted cash - end of the year 9,472,358 10,802,405 13,130,296
Cash 8,968,814 10,802,405 13,130,296
Restricted cash 503,544 0 0
Parent Company      
Cash flows from operating activities      
Net (loss) income attributable to Tungray Technologies Inc (480,019) 856,536 2,851,467
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities      
Equity loss (income) of subsidiaries 300,348 (856,536) (2,851,467)
Increase (Decrease) in Prepaid Expense (39,625) 0 0
Net cash used in operating activities (219,296) 0 0
Cash flows from investing activities      
Increase Decrease in Loans to subsidiaries (1,214,729) 0 0
Net cash used in investing activities (1,214,729) 0 0
Cash flows from financing activities      
Proceeds from issuance of shares upon IPO 5,000,000 0 0
Proceeds from issuance of shares pursuant to exercise of over-allotment 413,940 0 0
Payments of initial public offering costs (1,418,521) 0 0
Net cash provided by (used in) financing activities 3,995,419 0 0
Effect of exchange rate change on cash and restricted cash 0 0 0
Changes in cash and restricted cash 2,561,394 0 0
Cash and restricted cash - beginning of the year 0 0 0
Cash and restricted cash - end of the year 2,561,394 0 0
Cash 2,057,850 0 0
Restricted cash $ 503,544 $ 0 $ 0